KANTUM PHARMA
Kantum is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. This targeted therapy will be supported by development of a novel diagnostic test for AKI. Kantum Bio is developing two programs in parallel: (1) Selective receptor antagonist-based therapeutics for AKI and (2) a UDP-G diagnostic test. Kantum’s lead therapeutic development candidate, KB-1801, will be developed for the prophylaxis and treatment of AKI secondary to card... iovascular intervention. Furthermore, KB-1801 has potential in cardiovascular accidents and other conditions associated with AKI in the ICU (e.g. sepsis, polytrauma, nephrotoxicity). The UDP-G diagnostic test will enable early diagnosis of patients at risk for AKI and may be leveraged to select patients and guide their treatment in clinical studies and, ultimately, in clinical practice.
KANTUM PHARMA
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
Concord, New Hampshire, United States
Country:
United States
Website Url:
http://www.kantumpharma.com
Total Employee:
1+
Status:
Active
Contact:
603-876-6200
Total Funding:
3.53 M USD
Technology used in webpage:
Wix Wix DNS
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
Current Employees Featured
Founder
Investors List
Broadview Ventures
Broadview Ventures investment in Series A - Kantum Pharma
10X Venture Partners
10X Venture Partners investment in Series A - Kantum Pharma
Broadview Ventures
Broadview Ventures investment in Venture Round - Kantum Pharma
Sidecar Angels
Sidecar Angels investment in Convertible Note - Kantum Pharma
Official Site Inspections
http://www.kantumpharma.com Semrush global rank: 6.11 M Semrush visits lastest month: 1.33 K
- Host name: 192.64.119.3
- IP address: 192.64.119.3
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Kantum Pharma"
Kantum Pharma - VentureRadar
" Kantum Pharma is a privately-held biopharmaceutical company focused on developing therapies to prevent or reduce inflammation initiated through the Uridine Diphosphate (UDP) …See details»
Kantum Pharma - Crunchbase Company Profile
When was the last funding round for Kantum Pharma? Kantum Pharma closed its last funding round on Jul 12, 2021 from a Series A round. Who are Kantum …See details»
Kantum Pharma, Inc. - Drug pipelines, Patents, Clinical trials
Nov 1, 2024 Explore Kantum Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Technology Platform:Small molecule drug, Drug:KB-1801. Biomedical …See details»
Kantum Pharma - Overview, News & Similar companies - ZoomInfo
Kantum Pharma contact info: Phone number: (603) 876-6200 Website: www.kantumpharma.com What does Kantum Pharma do? Kantum Pharma Inc. (Kantum) is a biopharmaceutical …See details»
Kantum Pharma - Company Profile - Tracxn
Jul 14, 2024 Kantum Pharma - Developer of therapies for treating acute kidney injury. Raised a total funding of $3.53M over 1 round from 3 investors. Founded by Sylvie Breton in the year …See details»
Kantum Pharma's CEO and Executive Team - The Org
Kantum Pharma's CEO and Executive Team includes Glenn Batchelder and 2 others. Team members. Andrea Franz. Chief Financial Officer. Glenn Batchelder. Executive Chair. John …See details»
Kantum Pharma - Funding, Financials, Valuation & Investors
Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. Search Crunchbase. ... How much funding has this …See details»
Kantum Pharma - Crunchbase
Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. Search Crunchbase. Start Free Trial . Chrome …See details»
Kantum Pharma | CipherBio
Explore Kantum Pharma's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Kantum Pharma - Broadview Ventures
Kantum Pharma is a privately-held biopharmaceutical company focused on developing therapies to prevent or reduce inflammation initiated through the uridine diphosphate (UDP) …See details»
Kantum Pharma - Products, Competitors, Financials, Employees ...
Kantum Pharma was founded in 2016. Where is Kantum Pharma's headquarters? Kantum Pharma's headquarters is located at 75 S Main St #7-160, Concord. What is Kantum Pharma's …See details»
Kantum Pharma - VentureRadar
Kantum Pharma is a privately-held biopharmaceutical company focused on developing therapies to prevent or reduce inflammation initiated through the Uridine Diphosphate (UDP) …See details»
Kantum Pharma DMF, CEP, Written Confirmations, FDF
Kantum Pharma// Kantum Pharma was founded based on pioneering work from the laboratory of our scientific founder, Dr. Sylvie Breton, at MGH/Harvard Medical School. The Company is …See details»
Kantum Pharma - Raised $3.53M Funding from 3 investors - Tracxn
Dec 6, 2024 Kantum Pharma has raised a total funding of $3.53M over 1 round from 3 investors. Investors include Broadview Ventures, 10x Venture Partners and 1 other. Their latest funding …See details»
Kantum Pharma - Updates, News, Events, Signals & Triggers
Kantum Pharma is developing a specific AKI therapy to help critical care clinicians prevent hundreds of thousands of deaths from AKI. Search Crunchbase. Start Free Trial . Chrome …See details»
Kantum Pharma Founder to Present Preclinical Data …
Nov 4, 2019 Kantum Pharma is a privately-held biopharmaceutical company focused on developing therapies to prevent or reduce inflammation initiated through the Uridine …See details»
Kantum Pharma | Drug Developments | Pipeline Prospector
Find Suppliers : API/FDF. Search Our Integrated Database ; Services. Questionnaire For Your Search - Analytical - Analytical Method Development - Biologic Drugs - Capillary …See details»
Kantum Pharma - Contacts, Employees, Board Members
Organization. Kantum Pharma . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. …See details»
Kantum Pharma Highlights New Research Demonstrating …
May 27, 2020 Kantum Pharma is a privately held biopharmaceutical company focused on developing therapies to prevent or reduce inflammation initiated through the UDP …See details»
Kantum Pharma Highlights New Research ... - Broadview Ventures
CAMBRIDGE, Mass., May 27, 2020 /PRNewswire/ — Kantum Pharma Inc. (Kantum), a biopharmaceutical company focused on developing therapies for the prevention and treatment …See details»